Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Gets Nasdaq Non-compliance Letter

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has received a letter from Nasdaq saying that the firm's shares do not currently meet the exchange's requirements for minimum stockholders' equity.

The Melbourne, Australia-based firm said that the non-compliance was the result of its reported stockholders' equity as of Dec. 31, 2009 falling below the $10 million threshold as required by Nasdaq's rules.

Genetic Technologies has until April 18, 2010 to submit a plan to Nasdaq outlining its plans to regain compliance with the rule. If the plan is accepted, the firm may receive an extension of up to 180 days from March 4, 2010 to regain compliance.

Shares of Genetic Technologies closed at $1.27 in Monday trade on the Nasdaq. It currently has a market capitalization of around $15.5 million.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.